These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16253379)

  • 1. Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q10.
    Salles JE; Moisés VA; Almeida DR; Chacra AR; Moisés RS
    Diabetes Res Clin Pract; 2006 Apr; 72(1):100-3. PubMed ID: 16253379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation.
    Suzuki S; Hinokio Y; Ohtomo M; Hirai M; Hirai A; Chiba M; Kasuga S; Satoh Y; Akai H; Toyota T
    Diabetologia; 1998 May; 41(5):584-8. PubMed ID: 9628277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-cell function in individuals carrying the mitochondrial tRNA leu (UUR) mutation.
    Salles JE; Kasamatsu TS; Dib SA; Moisés RS
    Pancreas; 2007 Jan; 34(1):133-7. PubMed ID: 17198195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure.
    Sander S; Coleman CI; Patel AA; Kluger J; White CM
    J Card Fail; 2006 Aug; 12(6):464-72. PubMed ID: 16911914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of coenzyme Q10 in heart failure.
    Weant KA; Smith KM
    Ann Pharmacother; 2005 Sep; 39(9):1522-6. PubMed ID: 16046484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failure.
    Mortensen SA; Vadhanavikit S; Baandrup U; Folkers K
    Drugs Exp Clin Res; 1985; 11(8):581-93. PubMed ID: 3836876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of coenzyme Q10 in patients with kidney diseases].
    Gazdíková K; Gvozdjáková A; Kucharská J; Spustová V; Braunová Z; Dzúrik R
    Cas Lek Cesk; 2001 May; 140(10):307-10. PubMed ID: 11411060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coenzyme Q10 in dilated cardiomyopathy.
    Manzoli U; Rossi E; Littarru GP; Frustaci A; Lippa S; Oradei A; Aureli V
    Int J Tissue React; 1990; 12(3):173-8. PubMed ID: 2276896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coenzyme Q10: contractile dysfunction of the myocardial cell and metabolic therapy].
    Davini A; Cellerini F; Topi PL
    Minerva Cardioangiol; 1992 Nov; 40(11):449-53. PubMed ID: 1291925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coenzyme Q10 (ubiquinone) in the treatment of heart failure. Are any positive effects documented?].
    Spigset O
    Tidsskr Nor Laegeforen; 1994 Mar; 114(8):939-42. PubMed ID: 8191473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of chronic cardiac insufficiency with coenzyme Q10, results of meta-analysis in controlled clinical trials].
    Soja AM; Mortensen SA
    Ugeskr Laeger; 1997 Dec; 159(49):7302-8. PubMed ID: 9417729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research on coenzyme Q10 in clinical medicine and in immunomodulation.
    Folkers K; Wolaniuk A
    Drugs Exp Clin Res; 1985; 11(8):539-45. PubMed ID: 3836873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyopathy and kidney disease in a patient with maternally inherited diabetes and deafness caused by the 3243A>G mutation of mitochondrial DNA.
    Azevedo O; Vilarinho L; Almeida F; Ferreira F; Guardado J; Ferreira M; Lourenço A; Medeiros R; Almeida J
    Cardiology; 2010; 115(1):71-4. PubMed ID: 19864902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pronounced increase of survival of patients with cardiomyopathy when treated with coenzyme Q10 and conventional therapy.
    Langsjoen PH; Folkers K; Lyson K; Muratsu K; Lyson T; Langsjoen P
    Int J Tissue React; 1990; 12(3):163-8. PubMed ID: 2276894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of ubiquinone (coenzyme Q10) in pediatric cardiomyopathy.
    Bhagavan HN; Chopra RK
    Clin Nutr; 2005 Jun; 24(3):331-8. PubMed ID: 15896419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusual occurrence of intestinal pseudo obstruction in a patient with maternally inherited diabetes and deafness (MIDD) and favorable outcome with coenzyme Q10.
    Bergamin CS; Rolim LC; Dib SA; Moisés RS
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1345-9. PubMed ID: 19169492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beware the thin, deaf 'type 2' diabetic: maternally inherited diabetes and deafness with systemic (mitochondrial) manifestations.
    Jones DL; Greenaway TM
    Intern Med J; 2004 Aug; 34(8):517-8. PubMed ID: 15317555
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of coenzyme Q10 on catalase activity and other antioxidant parameters in streptozotocin-induced diabetic rats.
    Modi K; Santani DD; Goyal RK; Bhatt PA
    Biol Trace Elem Res; 2006 Jan; 109(1):25-34. PubMed ID: 16388100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of diabetic amyotrophy associated with 3243 mitochondrial tRNA(leu; UUR) mutation and successful therapy with coenzyme Q10.
    Suzuki Y; Kadowaki H; Atsumi Y; Hosokawa K; Katagiri H; Kadowaki T; Oka Y; Uyama K; Mokubo A; Asahina T
    Endocr J; 1995 Apr; 42(2):141-5. PubMed ID: 7542975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coenzyme Q10 and statins: biochemical and clinical implications.
    Littarru GP; Langsjoen P
    Mitochondrion; 2007 Jun; 7 Suppl():S168-74. PubMed ID: 17482884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.